RAMB - JULHO 2017

105 / 113

Mild cognitive impairment and progression to dementia of Alzheimer’s disease
Rev Assoc Med B ras 2017; 63(7):651-655 655
público de saúde, com altos custos. A identificação de
indivíduos com alteração cognitiva sem demência pode
adicionar planejamentos futuros por parte do próprio
doente, da sua família e dos cuidadores, resultando em
menor sobrecarga física e emocional para todos os envol-
vidos. Esta revisão narrativa tem como objetivo ajudar os
clínicos gerais a atuar na detecção dos idosos que se en-
contram em risco de desenvolver demência.
Palavras-chave: idoso, déficit cognitivo, comprometi-
mento cognitivo leve, clínico geral, doença de Alzheimer,
diagnóstico.
References
1. SPDM. A Saúde do Brasil em 2021 Reflexões sobre os desafios da próxima
década. 2012 [cited 2016 Sep 22]. Available from: .
br/anexos/saude_brasil.pdf.
2. IBGE. Brasil: uma visão geográfica e ambiental do inicio do século. In: Brasil:
uma visão geográfica e ambiental do inicio do século [Internet]. Instituto
Brasileiro de Geografia e Estatística; 2016 [cited 2016 Sep 22]. Available
from:
3. Araújo AC, Lotufo Neto F. A nova classificação americana para os transtornos
mentais: o DSM-5. Rev Bras Ter Comport Cogn [online]. 2014; 16(1):67-82.
4. Studart Neto A, Nitrini R. Subjective cognitive decline: the first clinical mani-
festation of Alzheimer’s disease? Dement Neuropsychol. 2016; 10(3):170-7.
5. Mendonça MD, Alves L, Bugalho P. From subjective cognitive complaints
to dementia: who is at risk? A systematic review. Am J Alzheimers Dis Other
Demen. 2016; 31(2):105-14.
6. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. Current
concepts in mild cognitive impairment. Arch Neurol. 2001; 58(12):1985-92.
7. Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale
for assessment of primary degenerative dementia. Am J Psychiatry. 1982;
139(9):1136-9.
8. Petersen RC, Caracciolo B, Brayne C, Gauthier S, Jelic V, Fratiglioni L. Mild cog-
nitive impairment: a concept in evolution. J InternMed. 2014; 275(3):214-28.
9. Forlenza OV, Diniz BS, Gattaz WF. Diagnosis and biomarkers of predementia
in Alzheimer’s disease. BMC Med. 2010; 8:89.
10. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund L-O, et al.
Mild cognitive impairment--beyond controversies, towards a consensus:
report of the International Working Group on Mild Cognitive Impairment.
J Intern Med. 2004; 256(3):240-6.
11. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al.
Toward defining the preclinical stages of Alzheimer’s disease:
recommendations from the National Institute on Aging-Alzheimer’s
Association workgroups on diagnostic guidelines for Alzheimer’s disease.
Alzheimers Dement. 2011; 7(3):280-92.
12. Zanuto E. Demência e transtornos cognitivos em idosos. Rev Bras Psiquiatr.
2006; 28(4):344-344.
13. Petersen, R. Early diagnosis of Alzheimer’s disease: is MCI too late? Current
Alzheimer Research. 2009; 6(4):324-30.
14. Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, et
al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol.
1991; 1(3):263-76.
15. Lopez OL, Jagust WJ, DeKosky ST, Becker JT, Fitzpatrick A, Dulberg C, et al.
Prevalence and classification of mild cognitive impairment in the Cardiovascular
Health Study Cognition Study: part 1. Arch Neurol. 2003; 60(10):1385-9.
16. Bennett DA, Wilson RS, Schneider JA, Evans DA, Beckett LA, Aggarwal NT,
et al. Natural history of mild cognitive impairment in older persons.
Neurology. 2002; 59(2):198-205.
17. Brucki SMD. Epidemiology of Mild Cognitive Impairment in Brazil. Dement
Neuropsychol. 2013; 7(4):363-6.
18. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global
prevalence of dementia: a systematic review and metaanalysis. Alzheimers
Dement. 2013; 9(1):63-75.e2.
19. Rodgers AB. Alzheimer’s disease: unraveling the mystery. US Department
of Health and Human Services. NIH Publication Number 08-3782. Septem-
ber 2008
20. Stein DJ, Kupfer DJ, Schatzberg AF, American Psychiatric Publishing,
organizers. The American Psychiatric Publishing textbook of mood disorders.
Washington, DC: American Psychiatric Pub; 2005. 778 p.
21. Gertz H-J, Arendt T. Alzheimer’s disease: from basic research to clinical
applications [Internet]. Wien; New York: Springer; 1998 [cited 2016 Sep 22].
Available from:
aspx?p=3099145.
22. Weintraub S, Wicklund AH, Salmon DP. The neuropsychological profi-
le of Alzheimer disease. Cold Spring Harb Perspect Med. 2012;
2(4):a006171.
23. Chaves ML, Godinho CC, Porto CS, Mansur L, Carthery-Goulart MT, Yassuda
MS, et al. Doença de Alzheimer. Avaliação cognitiva, comportamental e
funcional. Dement Neuropsychol. 2011; 5(Suppl 1):21-33.
24. Crowe M, Andel R, Wadley V, Cook S, Unverzagt F, Marsiske M, et al.
Subjective cognitive function and decline among older adults with
psychometrically defined amnestic MCI. Int J Geriatr Psychiatry. 2006;
21(12):1187-92.
25. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild
cognitive impairment: clinical characterization and outcome. Arch Neurol.
1999; 56(3):303-8.
26. Bottino CMC, Laks J, Blay SL. Demência e transtornos cognitivos em idosos.
Rio de Janeiro: Guanabara Koogan; 2006. 472 p.
27. Schmand B, Jonker C, Hooijer C, Lindeboom J. Subjective memory complaints
may announce dementia. Neurology. 1996; 46(1):121-5.
28. Schofield PW, Logroscino G, Andrews HF, Albert S, Stern Y. An association
between head circumference and Alzheimer’s disease in a population-based
study of aging and dementia. Neurology. 1997; 49(1):30-7.
29. Amoruso L, Ibáñez A, Fonseca B, Gadea S, Sedeño L, Sigman M, et al.
Variability in functional brain networks predicts expertise during action
observation. NeuroImage. 2017; 146:690-700.
30. Frota NAF, Nitrini R, Damasceno BP, Forlenza O, Dias-Tosta E, Silva AB,
et al. Critérios para o diagnóstico de doença de Alzheimer. Dement
Neuropsychol. 2011; 5(Suppl 1):5-10.
31. Sindi S, Mangialasche F, Kivipelto M. Advances in the prevention of
Alzheimer’s disease. F1000Prime Rep. 2015; 7:50.
32. Mattos P, Lino V, Rizo L, Alfano Â, Araújo C, Raggio R. Memory complaints
and test performance in healthy elderly persons. Arq Neuropsiquiatr. 2003;
61(4):920-4.
33. Chi GC, Fitzpatrick AL, Sharma M, Jenny NS, Lopez OL, DeKosky ST.
Inflammatory biomarkers predict domain-specific cognitive decline in older
adults. J Gerontol A Biol Sci Med Sci. 2017; 72(6):796-803
34. Damasceno BP. Neuroimaging in normal pressure hydrocephalus. Dement
Neuropsychol. 2015; 9(4):350-5.
35. Brucki SMD, Nitrini R, Caramelli P, Bertolucci PHF, Okamoto IH.
[Suggestions for utilization of the mini-mental state examination in Brazil].
Arq Neuropsiquiatr. 2003; 61(3B):777-81.
36. Jacinto AF, Brucki SMD, Porto CS, Martins MA, Nitrini R. Screening of
cognitive impairment by general internists using two simple instruments.
Dement Neuropsychol. 2012; 6(1):42-7.
37. Aguiar ACPO, Ribeiro MI, Jacinto AF. Subjective memory complaints in the
elderly may be related to factors other than cognitive deficit. Dement
Neuropsychol. 2010; 4(1):54-7.
38. Hohman TJ, Beason-Held LL, Lamar M, Resnick SM. Subjective cognitive
complaints and longitudinal changes in memory and brain function.
Neuropsychology. 2011; 25(1):125-30.
39. Li S, Okonkwo O, Albert M, Wang MC. Variation in variables that predict
progression from MCI to AD dementia over duration of follow-up. Am J
Alzheimers Dis (Columbia). 2013; 2(1):12-28.
40. Cooper C, Li R, Lyketsos C, Livingston G. Treatment for mild cognitive
impairment: systematic review. Br J Psychiatry. 2013; 203(3):255-64.
41. Chertkow H. Mild cognitive impairment. Curr Opin Neurol. 2002;
15(4):401-7.
42. Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, et
al.; Alzheimer’s Disease Cooperative Study Group. Vitamin E and donepezil
for the treatment of mild cognitive impairment. N Engl J Med. 2005;
352(23):2379-88.
43. Shinohara M, Yamada M. [Vitamin E and Alzheimer’s disease]. Brain Nerve.
2015; 67(12):1509-13.